State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
- PMID: 30657336
- PMCID: PMC7061293
- DOI: 10.1089/dia.2018.0384
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Erratum in
-
Correction to: Diabetes Technol Ther 2019;21(2):66-72.Diabetes Technol Ther. 2019 Apr;21(4):230. doi: 10.1089/dia.2018.0384.correx. Epub 2019 Mar 8. Diabetes Technol Ther. 2019. PMID: 30848935 Free PMC article. No abstract available.
Abstract
Objective: To provide a snapshot of the profile of adults and youth with type 1 diabetes (T1D) in the United States and assessment of longitudinal changes in T1D management and clinical outcomes in the T1D Exchange registry.
Research design and methods: Data on diabetes management and outcomes from 22,697 registry participants (age 1-93 years) were collected between 2016 and 2018 and compared with data collected in 2010-2012 for 25,529 registry participants.
Results: Mean HbA1c in 2016-2018 increased from 65 mmol/mol at the age of 5 years to 78 mmol/mol between ages 15 and 18, with a decrease to 64 mmol/mol by age 28 and 58-63 mmol/mol beyond age 30. The American Diabetes Association (ADA) HbA1c goal of <58 mmol/mol for youth was achieved by only 17% and the goal of <53 mmol/mol for adults by only 21%. Mean HbA1c levels changed little between 2010-2012 and 2016-2018, except in adolescents who had a higher mean HbA1c in 2016-2018. Insulin pump use increased from 57% in 2010-2012 to 63% in 2016-2018. Continuous glucose monitoring (CGM) increased from 7% in 2010-2012 to 30% in 2016-2018, rising >10-fold in children <12 years old. HbA1c levels were lower in CGM users than nonusers. Severe hypoglycemia was most frequent in participants ≥50 years old and diabetic ketoacidosis was most common in adolescents and young adults. Racial differences were evident in use of pumps and CGM and HbA1c levels.
Conclusions: Data from the T1D Exchange registry demonstrate that only a minority of adults and youth with T1D in the United States achieve ADA goals for HbA1c.
Keywords: Continuous glucose monitor use; Insulin pump use.; T1D Exchange registry.
Conflict of interest statement
No competing financial interests exist.
Figures



Comment in
-
State of Type 1 Diabetes Care in the United States in 2016-2018 from T1D Exchange Registry Data.Diabetes Technol Ther. 2019 Feb;21(2):62-65. doi: 10.1089/dia.2019.0008. Diabetes Technol Ther. 2019. PMID: 30707619 Free PMC article. No abstract available.
-
An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately.J Diabetes Sci Technol. 2020 Nov;14(6):983-986. doi: 10.1177/1932296819895083. Epub 2019 Dec 26. J Diabetes Sci Technol. 2020. PMID: 31876181 Free PMC article. No abstract available.
Similar articles
-
Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries.Diabetologia. 2014 Aug;57(8):1578-85. doi: 10.1007/s00125-014-3272-2. Epub 2014 Jun 4. Diabetologia. 2014. PMID: 24893863
-
The Transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D Exchange Registry and those included in the German/Austrian DPV registry.Diabet Med. 2020 May;37(5):848-855. doi: 10.1111/dme.14148. Epub 2019 Oct 14. Diabet Med. 2020. PMID: 31557351
-
POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.Endocr Pract. 2017 Oct;23(10):1201-1209. doi: 10.4158/EP171813.OR. Epub 2017 Jul 13. Endocr Pract. 2017. PMID: 28704103
-
Diabetes technology and treatments in the paediatric age group.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Int J Clin Pract Suppl. 2011. PMID: 21323816 Review.
-
A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.Pediatr Ann. 2019 Aug 1;48(8):e311-e318. doi: 10.3928/19382359-20190725-03. Pediatr Ann. 2019. PMID: 31426099 Review.
Cited by
-
Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes.Patient Prefer Adherence. 2020 Sep 28;14:1719-1731. doi: 10.2147/PPA.S262358. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 33061315 Free PMC article.
-
Rapid Adoption of Telemedicine Along with Emergent Use of Continuous Glucose Monitors in the Ambulatory Care of Young Persons with New-Onset Type 1 Diabetes in the Time of COVID-19: A Case Series.Telemed J E Health. 2022 Jan;28(1):107-114. doi: 10.1089/tmj.2020.0554. Epub 2021 Apr 15. Telemed J E Health. 2022. PMID: 33857385 Free PMC article.
-
Comorbidities increase COVID-19 hospitalization in young people with type 1 diabetes.Pediatr Diabetes. 2022 Nov;23(7):968-975. doi: 10.1111/pedi.13402. Epub 2022 Aug 28. Pediatr Diabetes. 2022. PMID: 36054578 Free PMC article.
-
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.Diabetes Technol Ther. 2022 Oct;24(10):712-725. doi: 10.1089/dia.2022.0201.pub. Diabetes Technol Ther. 2022. PMID: 36173237 Free PMC article. Clinical Trial.
-
Measuring glucose at the site of insulin delivery with a redox-mediated sensor.Biosens Bioelectron. 2020 Oct 1;165:112221. doi: 10.1016/j.bios.2020.112221. Epub 2020 Apr 29. Biosens Bioelectron. 2020. PMID: 32729464 Free PMC article.
References
-
- Beck RW, Tamborlane WV, Bergenstal RM, et al. : The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012;97:4383–4389 - PubMed
-
- Miller KM, Foster NC, Beck RW, et al. : Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015;38:971–978 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials